237 related articles for article (PubMed ID: 12377333)
1. Results of whole brain radiotherapy in patients with brain metastases from breast cancer: a retrospective study.
Mahmoud-Ahmed AS; Suh JH; Lee SY; Crownover RL; Barnett GH
Int J Radiat Oncol Biol Phys; 2002 Nov; 54(3):810-7. PubMed ID: 12377333
[TBL] [Abstract][Full Text] [Related]
2. Brain metastases from breast carcinoma: validation of the radiation therapy oncology group recursive partitioning analysis classification and proposition of a new prognostic score.
Le Scodan R; Massard C; Mouret-Fourme E; Guinebretierre JM; Cohen-Solal C; De Lalande B; Moisson P; Breton-Callu C; Gardner M; Goupil A; Renody N; Floiras JL; Labib A
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):839-45. PubMed ID: 17544592
[TBL] [Abstract][Full Text] [Related]
3. Whole brain radiotherapy for brain metastases from breast cancer: estimation of survival using two stratification systems.
Viani GA; Castilho MS; Salvajoli JV; Pellizzon AC; Novaes PE; Guimarães FS; Conte MA; Fogaroli RC
BMC Cancer; 2007 Mar; 7():53. PubMed ID: 17386108
[TBL] [Abstract][Full Text] [Related]
4. Application of recursive partitioning analysis and evaluation of the use of whole brain radiation among patients treated with stereotactic radiosurgery for newly diagnosed brain metastases.
Chidel MA; Suh JH; Reddy CA; Chao ST; Lundbeck MF; Barnett GH
Int J Radiat Oncol Biol Phys; 2000 Jul; 47(4):993-9. PubMed ID: 10863070
[TBL] [Abstract][Full Text] [Related]
5. Outcome and prognostic factors in patients with brain metastases from small-cell lung cancer treated with whole brain radiotherapy.
Bernhardt D; Adeberg S; Bozorgmehr F; Opfermann N; Hoerner-Rieber J; König L; Kappes J; Thomas M; Herth F; Heußel CP; Warth A; Debus J; Steins M; Rieken S
J Neurooncol; 2017 Aug; 134(1):205-212. PubMed ID: 28560661
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.
Caballero JA; Sneed PK; Lamborn KR; Ma L; Denduluri S; Nakamura JL; Barani IJ; McDermott MW
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):303-9. PubMed ID: 22079723
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors affecting the outcome of brain metastases from breast cancer.
Liu MT; Hsieh CY; Wang AY; Chang TH; Pi CP; Huang CC; Huang CY; Liou CH
Support Care Cancer; 2006 Sep; 14(9):936-42. PubMed ID: 16575571
[TBL] [Abstract][Full Text] [Related]
8. A matched-pair analysis comparing whole-brain radiotherapy plus stereotactic radiosurgery versus surgery plus whole-brain radiotherapy and a boost to the metastatic site for one or two brain metastases.
Rades D; Kueter JD; Pluemer A; Veninga T; Schild SE
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1077-81. PubMed ID: 18707817
[TBL] [Abstract][Full Text] [Related]
9. A boost in addition to whole-brain radiotherapy improves patient outcome after resection of 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients.
Rades D; Pluemer A; Veninga T; Dunst J; Schild SE
Cancer; 2007 Oct; 110(7):1551-9. PubMed ID: 17654659
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of 2 whole-brain radiotherapy schedules and prognostic factors for brain metastases in breast cancer patients.
Rades D; Lohynska R; Veninga T; Stalpers LJ; Schild SE
Cancer; 2007 Dec; 110(11):2587-92. PubMed ID: 17893909
[TBL] [Abstract][Full Text] [Related]
11. Systemic treatment after whole-brain radiotherapy may improve survival in RPA class II/III breast cancer patients with brain metastasis.
Zhang Q; Chen J; Yu X; Ma J; Cai G; Yang Z; Cao L; Chen X; Guo X; Chen J
J Neurooncol; 2013 Sep; 114(2):181-9. PubMed ID: 23743596
[TBL] [Abstract][Full Text] [Related]
12. Comparison of short-course versus long-course whole-brain radiotherapy in the treatment of brain metastases.
Rades D; Bohlen G; Dunst J; Lohynska R; Veninga T; Stalpers L; Schild SE; Dahm-Daphi J
Strahlenther Onkol; 2008 Jan; 184(1):30-5. PubMed ID: 18188520
[TBL] [Abstract][Full Text] [Related]
13. Do patients receiving whole-brain radiotherapy for brain metastases from renal cell carcinoma benefit from escalation of the radiation dose?
Rades D; Heisterkamp C; Schild SE
Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):398-403. PubMed ID: 20488627
[TBL] [Abstract][Full Text] [Related]
14. Survival by radiation therapy oncology group recursive partitioning analysis class and treatment modality in patients with brain metastases from malignant melanoma: a retrospective study.
Buchsbaum JC; Suh JH; Lee SY; Chidel MA; Greskovich JF; Barnett GH
Cancer; 2002 Apr; 94(8):2265-72. PubMed ID: 12001126
[TBL] [Abstract][Full Text] [Related]
15. Radiosurgery for patients with brain metastases: a multi-institutional analysis, stratified by the RTOG recursive partitioning analysis method.
Sanghavi SN; Miranpuri SS; Chappell R; Buatti JM; Sneed PK; Suh JH; Regine WF; Weltman E; King VJ; Goetsch SJ; Breneman JC; Sperduto PW; Scott C; Mabanta S; Mehta MP
Int J Radiat Oncol Biol Phys; 2001 Oct; 51(2):426-34. PubMed ID: 11567817
[TBL] [Abstract][Full Text] [Related]
16. Reduction of overall treatment time in patients irradiated for more than three brain metastases.
Rades D; Kieckebusch S; Lohynska R; Veninga T; Stalpers LJ; Dunst J; Schild SE
Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1509-13. PubMed ID: 17689033
[TBL] [Abstract][Full Text] [Related]
17. Institutional, retrospective analysis of 777 patients with brain metastases: treatment outcomes and diagnosis-specific prognostic factors.
Antoni D; Clavier JB; Pop M; Schumacher C; Lefebvre F; Noël G
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):630-7. PubMed ID: 23582409
[TBL] [Abstract][Full Text] [Related]
18. Whole-brain radiotherapy with 20 Gy in 5 fractions for brain metastases in patients with cancer of unknown primary (CUP).
Rades D; Bohlen G; Lohynska R; Veninga T; Stalpers LJ; Schild SE; Dunst J
Strahlenther Onkol; 2007 Nov; 183(11):631-6. PubMed ID: 17960339
[TBL] [Abstract][Full Text] [Related]
19. Whole brain radiotherapy: prognostic factors and results of a radiation boost delivered through a conventional linear accelerator.
Assouline A; Levy A; Chargari C; Lamproglou I; Mazeron JJ; Krzisch C
Radiother Oncol; 2011 May; 99(2):214-7. PubMed ID: 21620502
[TBL] [Abstract][Full Text] [Related]
20. Breast cancer brain metastases: differences in survival depending on biological subtype, RPA RTOG prognostic class and systemic treatment after whole-brain radiotherapy (WBRT).
Niwińska A; Murawska M; Pogoda K
Ann Oncol; 2010 May; 21(5):942-8. PubMed ID: 19840953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
